VIVS - VivoSim Labs Inc Sales Growth YoY (Last 12 Months)

Despite external geopolitical uncertainty, VivoSim Labs Inc (VIVS) operates within a secure US legal framework. The rolling annual sales growth trend visualizes revenue dynamics, where -3.50 shows the current value of the metric. Stability is confirmed by transparent management protecting patents, while the implementation of industrial robotics in bioprinting eliminates manual labor errors, guaranteeing the precision accuracy of samples.
Summary analytical data breakdowns for Organovo (VIVS)

This indicator measures business expansion rates by comparing current trailing twelve-month revenue with the same period last year to filter out short-term fluctuations. By analyzing the annual revenue growth trend over the TTM period, an investor can assess the viability of VivoSim Labs Inc. (VIVS) given the company's critical dependence on the narrow 3D bioprinting segment and a lack of market diversification.